Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Clinical Characteristics at Initiation of Canakinumab Therapy (n=19).
| Male, n (%) | 9 (47) |
|---|---|
| Age at diagnosis, n (%) | |
| <1 year | 9 (47) |
| 1 to <6 years | 10 (53) |
| Age at canakinumab initiation, n (%) | |
| <1 year | 7 (37) |
| 1 to <6 years | 7 (37) |
| 6 to <10 years | 4 (21) |
| ≥10 | 1 (5) |
| IBD subtype, n (%) | |
| IBD-U | 11 (58) |
| CD | 8 (42) |
| Disease Phenotype, n (%) | |
| Inflammatory only | 18 (95) |
| Stricturing | 1 (5) |
| Disease Location, n (%) | |
| Colonic | 15 (83) |
| Pan-enteric | 2 (11) |
| Ileocolonic | 1 (6) |
| Perianal involvement | 3 (17) |
